-
Mashup Score: 0Episode 16: Update from the American Heart Association 2024 Science Meeting from 2024 - 5 day(s) ago
Podcast Episode · Heart Corner: Innovations in Cardiovascular Science · 11/18/2024 · 20m
Source: podcasts.apple.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1
The first trial examines the effects of tirzepatide on patients with heart failure with preserved ejection fraction and obesity. The study found that tirzepatide significantly reduced the risk of death from cardiovascular causes or worsening heart failure compared to placebo, improving health status and exercise tolerance. The second trial evaluates the use of colchicine in patients who have experienced an acute myocardial infarction, finding no significant reduction in the composite outcome of death from cardiovascular causes, recurrent myocardial infarction, stroke, or unplanned ischemia-driven coronary revascularization despite a longer treatment duration. The third trial reports on the use of spironolactone in patients who have experienced an acute myocardial infarction, with the results demonstrating no significant decrease in the risk of death from cardiovascular causes or new or worsening heart failure or the composite outcome of death from cardiovascular causes, myocardial infa
Source: creators.spotify.comCategories: General Medicine News, CardiologistsTweet-
Listen to "Episode 16: Update from the American Heart Association 2024 Science Meeting from 2024" by Heart Corner: Innovations in Cardiovascular Science. 🥸Many thanks to @AHAScience for great meeting: #AHA24 👇👇👇 https://t.co/w3jhxBeh2u
-
-
Mashup Score: 2
Introduction: Older adults face a high burden of cardiovascular disease (CVD), exacerbated by geriatric conditions such as multimorbidity and polypharmacy. The collective influence on CVD risk remains unclear. We hypothesize that the coexistence of multiple geriatric syndromes increases the risk of incident CVD events . Methods: We conducted a cross-sectional study among individuals aged 45–64 years using a logistic regression to assess the association between geriatric syndrome(had ≥3factors) and CVD events at the end of Visit 5(period prevalence) in the Atherosclerosis Risk in Communities(ARIC study). We examined the following geriatric conditions: multimorbidity (≥2 chronic conditions), polypharmacy (≥5 medications), cognitive impairment vision impairment, hearing impairment, urinary incontinence, functional decline, frailty, and sarcopenia. Primary outcome was prevalence of 3-point MACE, defined as: death, acute myocardial infarction (AMI), or stroke. Results: Among the 5,141 parti
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
Congratulations to Kehinde Tom-Ayegunle for her hard working putting this work together: @AHAScience #AHA24 👇👇👇 https://t.co/O1wxZxaDGI
-
-
Mashup Score: 0Episode 15: Heart Matters: Bridging the Care Gap in Cardiac Interventions for Older Women by Heart Corner: Innovations in Cardiovascular Science - 10 day(s) ago
This medical paper examines the challenges older women face when undergoing percutaneous coronary intervention (PCI) for coronary artery disease. The authors highlight that older women are less likely to receive evidence-based treatment despite experiencing a higher risk of adverse events due to their unique physiological and anatomical differences. The paper discusses the limitations of current risk stratification tools in accurately assessing older women’s risk, and emphasizes the need for tailored procedural techniques and patient-centered care approaches. Furthermore, it calls attention to the limited research available on older women and the need for increased representation in clinical trials.
Source: creators.spotify.comCategories: General Medicine News, CardiologistsTweet-
🥸Listen to "Episode 15: Heart Matters: Bridging the Care Gap in Cardiac Interventions for Older Women" by Heart Corner: Innovations in Cardiovascular Science. 👇👇👇 https://t.co/XSew1DVaft
-
-
Mashup Score: 0Bridging Care Gaps for Older Women Undergoing Percutaneous Coronary Intervention - PubMed - 10 day(s) ago
This paper reviews the distinct clinical, pathophysiological, and therapeutic challenges faced by older women undergoing percutaneous coronary intervention (PCI). Older women present with a greater comorbidity burden, smaller coronary vessels, and post-menopausal hormonal changes, which increase pro …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
😱Citation: https://t.co/7NjEE3ttUZ Thanks to @ElsevierConnect for the opportunity.
-
-
Mashup Score: 2
AI: Artificial, Augmented or Abused Intelligence? Integrating AI into Healthcare Services November 18, 2024 2:30 pm – 4:00 pm (GMT) / 9:30 am – 11:00 am EST Given the rapid development of Artificial Intelligence (AI) in healthcare, it is no surprise that many practitioners are puzzled about it. There is tremendous excitement around its deployment and the ways it could dramatically transform the field. But can it truly improve healthcare? Could it be a magic bullet or is it all hype? AI’s application in both clinical and non-clinical areas promises better and more efficient healthcare delivery and to dramatically alter the way healthcare is practiced. This webinar will answer the following: • What is the role of AI in transforming healthcare delivery and enhancing patient outcomes? • What are the benefits and drawbacks? • What are the responsible and best practices of AI use in healthcare? Language: English and Spanish interpretation This event is organized by the IFC, a member of the W
Source: worldbankgroup.zoom.usCategories: General Medicine News, CardiologistsTweet-
📣 AI in Health Care Webinar IFC (World Bank)!📣 Clinicians and leaders grappling with implementing artificial intelligence in Healthcare Services are invited on Monday, November 18, at 9:30 EST for #DigiHealth webinar. ✅ Register here: https://t.co/rbS1I7nmpb @MiriamZaki https://t.co/dttn5DN7wK
-
-
Mashup Score: 1
The average lifespan of humans is increasing, and with it the percentage of people entering the 65 and older age group is growing rapidly and will continue to do so in the next 20 years. Within this age group, cardiovascular disease will remain the leading cause of death, and the cost associated with treatment will continue to increase. Aging is an inevitable part of life and unfortunately poses the largest risk factor for cardiovascular disease. Although numerous studies in the cardiovascular field have considered both young and aged humans, there are still many unanswered questions as to how the genetic pathways that regulate aging in model organisms influence cardiovascular aging. Likewise, in the molecular biology of aging field, few studies fully assess the role of these aging pathways in cardiovascular health. Fortunately, this gap is beginning to close, and these two fields are merging together. We provide an overview of some of the key genes involved in regulating lifespan and
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
🥸2️⃣1️⃣ CV Basic Science & Aging: Foundational science in CV medicine. Full link: https://t.co/15MkhLoVOx
-
-
Mashup Score: 1
AbstractWhereas the burgeoning population of older adults is intrinsically vulnerable to cardiovascular disease, the utility of many management precepts that were validated in younger adults is oft…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
🥸2️⃣0️⃣ CV Biomarkers & Aging: Key biomarkers in aging @JACCJournals. Full link: https://t.co/mnlgu0GSef
-
-
Mashup Score: 2
AbstractAging and inflammation both contribute pivotally to cardiovascular (CV) and cerebrovascular disease, the leading causes of death and disability worldwide. The concept of inflamm-aging recog…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
🥸1️⃣7️⃣ Inflammation & Aging: Role of inflammation in aging hearts. 😱Full link: https://t.co/cPjZfx1Ih2
-
-
Mashup Score: 0Gerotechnology for Older Adults With Cardiovascular Diseases: JACC State-of-the-Art Review - PubMed - 12 day(s) ago
The growing population of older adults (age ≥65 years) is expected to lead to higher rates of cardiovascular disease. The expansion of digital health (encompassing telehealth, telemedicine, mobile health, and remote patient monitoring), Internet access, and cellular technologies provides an opportun …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
🥸1️⃣6️⃣ Gerotechnology & Aging: Tech advancements for aging care: @cardskrish Full link: https://t.co/OnMXEetojD
-
Episode 16 Update from #AHA24 👇👇👇 https://t.co/4RIimXPQtJ